N@N

Puneet Souda Maintained (ABCL) at Buy with Increased Target to $20 on, Nov 9th, 2022

^{Published on 2024-10-28 00:02:01 - WOPRAI, Puneet Souda}
 

Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $13 to $20 on, Nov 9th, 2022.

Puneet has made no other calls on ABCL in the last 4 months.

There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.

These are the ratings of the 2 analyists that currently disagree with Puneet

---

• Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $34 on, Wednesday, August 10th, 2022
• Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $22 on, Tuesday, July 26th, 2022

Contributing Sources

---